The Year in Hypertension

Journal of the American College of Cardiology

Volumn 55, Issue 1, 2009, Pages 65-73

  Williams, Bryan ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

blood; hypertension; pressure

Indexed keywords

ALISKIREN; AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTILIPEMIC AGENT; BENAZEPRIL; CALCIUM CHANNEL BLOCKING AGENT; CHLORTALIDONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOXAZOSIN; HYDROCHLOROTHIAZIDE; INDAPAMIDE; LISINOPRIL; LOSARTAN; PERINDOPRIL; PLACEBO; RAMIPRIL; TELMISARTAN;

BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR DISEASE; CLINICAL PRACTICE; COGNITION; DAIRY PRODUCT; DIABETIC NEPHROPATHY; HEART FAILURE; HUMAN; HYPERTENSION; KIDNEY DISEASE; LOW DRUG DOSE; MORBIDITY; MORTALITY; NUTRITIONAL ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEINURIA; RECOMMENDED DRUG DOSE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; STROKE;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE MONITORING, AMBULATORY; DAIRY PRODUCTS; HUMANS; HYPERTENSION; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 72549094547     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2009.08.037     Document Type: Review

References (34)

1. Lawes C.M.M., Vander Hoorn S., and Rodgers A. Global burden of blood pressure-related disease, 2001. Lancet 371 (2008) 1513-1518
2. Pickering T.G., Houston Miller N., Ogedegbe G., Krakoff L.R., Artinian N.T., and Goff D. Call to action on use and reimbursement for home blood pressure monitoring: a joint scientific statement from the American Heart Association, American Society of Hypertension, and Preventive Cardiovascular Nurses Association. Hypertension 52 (2008) 10-29
3. Williams B. The year in hypertension. J Am Coll Cardiol 51 (2008) 1803-1817
4. Moore L.L., Singer M.R., Bradlee M.L., et al. Intake of fruits, vegetables, and dairy products in early childhood and subsequent blood pressure change. Epidemiology 16 (2005) 4-11
5. Pereira M.A., Jacobs Jr. D.R., Van Horn L., Slattery M.L., Kartashov A.I., and Ludwig D.S. Dairy consumption, obesity, and the insulin resistance syndrome in young adults: the CARDIA study. JAMA 287 (2002) 2081-2089
6. Choi H.K., Willett W.C., Stampfer M.J., Rimm E., and Hu F.B. Dairy consumption and risk of type 2 diabetes mellitus in men: a prospective study. Arch Intern Med 165 (2005) 997-1003
7. Bostick R.M., Kushi L.H., Wu Y., Meyer K.A., Sellers T.A., and Folsom A.R. Relation of calcium, vitamin D, and dairy food intake to ischemic heart disease mortality among postmenopausal women. Am J Epidemiol 149 (1999) 151-161
8. Wang L., Manson J.E., Buring J.E., Lee I.M., and Sesso H.D. Dietary intake of dairy products, calcium, and vitamin D and the risk of hypertension in middle-aged and older women. Hypertension 51 (2008) 1073-1079
9. ONTARGET Study Investigators. Telmisartan, ramipril, or both inpatients at high risk for vascular events. N Engl J Med 358 (2008) 1547-1559
10. The Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 342 (2000) 145-153
11. Sleight P., Redon J., Verdecchia P., et al. Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study. J Hypertens 27 (2009) 1360-1369
12. Williams B., Gosse P., Lowe L., and Harper R. The prospective, randomized investigation of the safety and efficacy of telmisartan versus ramipril using ambulatory blood pressure monitoring (PRISMA I). J Hypertens 24 (2006) 193-200
13. Mann J.F.E., Schmieder R.E., McQueen M., et al. Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial. Lancet 372 (2008) 547-553
14. Parving H.H., Persson F., Lewis J.B., Lewis E.J., Hollenberg N.K., and AVOID Study Investigators. Aliskiren combined with losartan in type 2 diabetes and nephropathy. N Engl J Med 358 (2008) 2433-2446
15. Parving H.H., Brenner B.M., McMurray J.J., et al. Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): rationale and study design. Nephrol Dial Transplant 24 (2009) 1663-1671
16. The Telmisartan Randomised Assessment Study in ACE Intolerant Subjects With Cardiovascular Disease (TRANSCEND) Investigators. Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial. Lancet 27; (2008) 372 1174-83
17. Lithell H., Hansson L., Skoog I., et al., SCOPE Study Group. The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial. J Hypertens 21 (2003) 875-886
18. Yusuf S., Diener H.C., Sacco R.L., et al. Randomized trial of early telmisartan therapy to prevent recurrent strokes and major vascular events among 20,000 individuals with previous stroke. N Engl J Med 359 (2008) 1225-1237
19. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet 358 (2001) 1033-1041
20. Dahlöf B., Devereux R.B., Kjeldsen S.E., et al. Cardiovascular morbidity and mortality in the Losartan Intervention for Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 359 (2002) 995-1003
21. Bulpitt C.J., Beckett N.S., Cooke J., et al. Results of the pilot study for the Hypertension in the Very Elderly Trial. J Hypertens 21 (2003) 2409-2417
22. Beckett N.S., Peters R., Fletcher A.E., Staessen J.A., Liu L., and Dumitrascu D. Treatment of hypertension in patients 80 years of age or older. N Engl J Med 358 (2008) 1887-1898
23. Peters R., Beckett N., Forette F., et al. Incident dementia and blood pressure lowering in the very elderly: a double-blind, placebo controlled trial. Lancet Neurol 8 (2008) 683-689
24. Davis B.R., Kostis J.B., Simpson L.M., et al. Heart failure with preserved and reduced left ventricular ejection fraction in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Circulation 118 (2008) 2259-2267
25. Jamerson K., Weber M.A., Bakris G.L., et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med 359 (2008) 2417-2428
26. Chobanian A.V., Bakris G.L., Black H.R., et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 289 (2003) 2560-2572
27. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). 2007 guidelines for the management of arterial hypertension. J Hypertens 25 (2007) 1105-1187
28. Calhoun D.A., Jones D., Textor S., et al. Resistant hypertension: diagnosis, evaluation and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension 51 (2008) 1403-1419
29. Protogerou A., Blacher J., Stergiou G.S., Achimastos A., and Safar M.E. Blood pressure response under chronic antihypertensive drug therapy: the role of aortic stiffness in the REASON (Preterax in Regression of Arterial Stiffness in a Controlled Double-Blind) study. J Am Coll Cardiol 53 (2009) 445-451
30. Williams B. The aorta and resistant hypertension. J Am Coll Cardiol 53 (2009) 452-454
31. Williams B., Lindhom L.H., and Sever P.S. Systolic pressure is all that matters. Lancet 371; (2008) 2219-2221
32. Krum H., Schlaich M., Whitbourn R., et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet 373 (2009) 1275-1281
33. Higgens B., Williams B., and Guideline Development Group. Pharmacological management of hypertension. Clin Med 7 (2007) 612-616
34. Feldman R.D., Zou G.Y., Vandervoort M.K., Wong C.J., Nelson S.A.E., and Feagan B.G. A simplified approach to the treatment of uncomplicated hypertension: a cluster randomized, controlled trial. Hypertension 53 (2009) 646-653